Literature DB >> 6996612

Principal beta-lactamases responsible for resistance to beta-lactam antibiotics in urinary tract infections.

I N Simpson, P B Harper, C H O'Callaghan.   

Abstract

Two independent surveys have been conducted to determine the prevalent bacterial species and beta-lactamase types present in clinical populations of gram-negative, ampicillin-resistant isolates. A total of 208 isolates (112 from Nottingham Hospital and 96 from Charing Cross Hospital), all of which had been collected from out-patients suffering from urinary tract infections, were investigated. The incidence of ampicillin-resistant isolates (minimum inhibitory concentrations, 8 micrograms/ml) was 24.1% and 18.8% within the Nottingham and Charing Cross samples, respectively. The surveys gave similar results within the ampicillin-resistant samples. Escherichia coli was the prevalent bacterial species (52.9%), followed by Klebseilla pneumoniae (30.3%). The majority of isolates, at least 54.8% and possibly as high as 74.5%, owed their principal beta-lactamase activity to enzymes mediated by R-plasmids. The most prevalent beta-lactamases were TEM-1 (53.3%), SHV-1 (30.9%), and OXA-1 (11.5%). Positive associations were found between E. coli and TEM-1 or OXA-1 and between K. pneumoniae and SHV-1.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6996612      PMCID: PMC283905          DOI: 10.1128/AAC.17.6.929

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Penicillin resistance in Escherichia coli K12: synergism between penicillinases and a barrier in the outer part of the envelope.

Authors:  H G Boman; K Nordström; S Normark
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

2.  The chromosomal integration of a -lactamase gene derived from the P-type R-factor RP1 in Escherichia coli.

Authors:  M H Richmond; R B Sykes
Journal:  Genet Res       Date:  1972-10       Impact factor: 1.588

Review 3.  Mechanisms of bacterial resistance to antibiotics.

Authors:  J S Pitton
Journal:  Ergeb Physiol       Date:  1972

4.  The molecule of infectious drug resistance.

Authors:  R C Clowes
Journal:  Sci Am       Date:  1973-04       Impact factor: 2.142

5.  Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae.

Authors:  N Datta; P Kontomichalou
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

6.  Characterization of the -lactamase specified by the resistance factor R-1818 in E. coli K12 and other Gram-negative bacteria.

Authors:  J W Dale
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857

7.  Infectious drug resistance.

Authors:  T Watanabe
Journal:  Sci Am       Date:  1967-12       Impact factor: 2.142

8.  Molecular specificities of R factor-determined beta-lactamases: correlation with plasmid compatibility.

Authors:  R W Hedges; N Datta; P Kontomichalou; J T Smith
Journal:  J Bacteriol       Date:  1974-01       Impact factor: 3.490

9.  Comparison of the substrate specificities of the -lactamases from Klebsiella aerogenes 1082E and Enterobacter cloacae P99.

Authors:  M J Marshall; G W Ross; K V Chanter; A M Harris
Journal:  Appl Microbiol       Date:  1972-04

10.  The purification and properties of a penicillinase whose synthesis is mediated by an R-factor in Escherichia coli.

Authors:  N Datta; M H Richmond
Journal:  Biochem J       Date:  1966-01       Impact factor: 3.857

View more
  24 in total

1.  Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.

Authors:  N G Brown; T Palzkill
Journal:  Protein Eng Des Sel       Date:  2010-03-22       Impact factor: 1.650

Review 2.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  Monoclonal antibodies to TEM-1 plasmid-mediated beta-lactamase.

Authors:  C J Morin; P C Patel; R C Levesque; R Letarte
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

Review 4.  Past and Present Perspectives on β-Lactamases.

Authors:  Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 5.  β-Lactams and β-Lactamase Inhibitors: An Overview.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

6.  In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

Authors:  R N Jones; A L Barry; R R Packer; W W Gregory; C Thornsberry
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

7.  Molecular hybridization versus isoelectric focusing to determine TEM-type beta-lactamases in gram-negative bacteria.

Authors:  M Jouvenot; M L Deschaseaux; M Royez; C Mougin; R C Cooksey; Y Michel-Briand; G L Adessi
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

8.  Frequency of plasmid-determined beta-lactamases in 680 consecutively isolated strains of Enterobacteriaceae.

Authors:  C Roy; C Segura; M Tirado; R Reig; M Hermida; D Teruel; A Foz
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

9.  In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.

Authors:  R N Jones
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.

Authors:  C Hal Jones; Alexey Ruzin; Margareta Tuckman; Melissa A Visalli; Peter J Petersen; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.